Advertisement
Screener

Zyla Life Sciences Form 425: Prospectus or communication for a business combination

Zyla Life Sciences Form 425: Prospectus or communication for a business combination

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2020-05-15: Form 425; Description FORM 8-K; Document tm2019860d2_8k.htm.
  • 2020-05-15: Form 425; Description 425; Document tm2019860-3_425.htm.
  • 2020-04-13: Form 425; Description FORM 8-K; Document tm2015601-1_8k.htm.
  • 2020-03-27: Form 425; Description FORM 8-K; Document tm2012940-2_8k.htm.
FiledFormPeriod of reportDescriptionDocument
2020-05-15425FORM 8-Ktm2019860d2_8k.htm
2020-05-15425425tm2019860-3_425.htm
2020-04-13425FORM 8-Ktm2015601-1_8k.htm
2020-03-27425FORM 8-Ktm2012940-2_8k.htm
2020-03-17425FORM 8-Ktm2012940d1_8k.htm